Debate is flaring up over whether pharmacists should be able to switch patients to biosimilar medicines. As part of its PBS reform package,

Substitution stoush

Pharmacy News-18 hours ago

Debate is flaring up over whether pharmacists should be able to switch patients to biosimilar medicines. As part of its PBS reform package, currently before the ...

A call for clarity in policy around drugs known as “biosimilars”
Crikey (registration) (blog)-18 hours ago

Explore in depth  (3 more articles)